Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Castellani

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Experimental Physiology|July 7, 2023
Memory impairment in the D2.mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688Catherine A Bellissimo, Laura N Castellani, Michael S Finch, et al.
Medicine and Science in Sports and Exercise|January 30, 2019
Regulation of Hepatic Follistatin Expression at Rest and during Exercise in MiceWillem T Peppler, Laura N Castellani, Jared Root-McCaig, et al.
Psychoneuroendocrinology|February 10, 2024
Olanzapine's effects on hypothalamic transcriptomics and kinase activitySandra Pereira, Laura N Castellani, Chantel Kowalchuk, et al.
Molecular Psychiatry|October 14, 2022
Antipsychotics impair regulation of glucose metabolism by central glucoseLaura N Castellani, Sandra Pereira, Chantel Kowalchuk, et al.
American Journal of Physiology. Cell Physiology|December 25, 2023
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.<i>mdx</i> mouse model of Duchenne muscular dystrophyCatherine A Bellissimo, Shivam Gandhi, Laura N Castellani, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Experimental Physiology|July 7, 2023
Memory impairment in the D2.mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688Catherine A Bellissimo, Laura N Castellani, Michael S Finch, et al.
Medicine and Science in Sports and Exercise|January 30, 2019
Regulation of Hepatic Follistatin Expression at Rest and during Exercise in MiceWillem T Peppler, Laura N Castellani, Jared Root-McCaig, et al.
Psychoneuroendocrinology|February 10, 2024
Olanzapine's effects on hypothalamic transcriptomics and kinase activitySandra Pereira, Laura N Castellani, Chantel Kowalchuk, et al.
Molecular Psychiatry|October 14, 2022
Antipsychotics impair regulation of glucose metabolism by central glucoseLaura N Castellani, Sandra Pereira, Chantel Kowalchuk, et al.
American Journal of Physiology. Cell Physiology|December 25, 2023
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.<i>mdx</i> mouse model of Duchenne muscular dystrophyCatherine A Bellissimo, Shivam Gandhi, Laura N Castellani, et al.
Pageof 2